Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 964

DECLARATION re #963 Opposition to Motion OF AARON R. HAND by Amgen Inc.. (Attachments: #1 Exhibit 1#2 Exhibit 2#3 Exhibit 3#4 Exhibit 4#5 Exhibit 5#6 Exhibit 6#7 Exhibit 7#8 Exhibit 8#9 Exhibit 9)(Gottfried, Michael)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 964 Att. 1

Case 1:05-cv-12237-WGY

Document 964-2

Filed 09/03/2007

Page 1 of 2

EXHIBIT 1

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 964-2

Filed 09/03/2007

Page 2 of 2

DAY CASEBEER MADRID & BATCHELDER LLP

20300 Stevens Creek Blvd., Suite 400 Cupertino, CA 95014 Telephone : [phone] Facsimile: [phone] July 30, 2007 VIA E-MAIL Thomas F . Fleming Kaye Scholer LLP 425 Park Avenue New York, NY 10022-3598 Re :

Renee DuBord Brown [phone] rbrown@ daycasebeer .com

Amgen Inc. v. F. Hoffman-Roche, Ltd., et al.
Civil Action No : 05-12237-WGY

Dear Tom : Roche has designated as live witnesses Patrick Horber, Bruno Reigner, and Daniel Shouval . Thus per our agreement, Amgen does not expect to receive counterdesignations at this time from Roche for these witnesses . Similarly, Amgen has designated as live trial witnesses Michael Borun, Ralph Bradshaw, Jeffrey Browne, Joan Egrie, Steven Elliott, Eugene Goldwasser, Fu-Kuen Lin, Steven Odre, Thomas Strickland, Helen Torley, Axel Ullrich and Stuart Watt as live trial witnesses, and will not be providing counterdesignations at this time . However, I would like to meet-and-confer with you regarding the process and timing of providing counterdesignations should one or the other party determine not to call one or more of these witnesses live . In addition, we should meet-and-confer regarding your proposal on the exchanges of demonstratives, designations, and other materials during trial . Please let me know if you are available Wednesday, August 1 at 10 am Pacific (1 pm Eastern) . Regards, DAY CASEBEER MADRID & BATCHELDER LLP

Renee DuBord Brown RB :paw

745853